Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-15

Clinical Trial Update: Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial of oxaliplatin and capecitabine with or without hepatic arterial infusion of floxuridine in patients undergoing surgery or ablation for colorectal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • Floxuridine (floxuridine)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 3 | Status: TERMINATED | Results posted: 2013-03-15